Browsing by Author "Bilen, Ömer"
Now showing items 1-5 of 5
-
Architectural design communication (ADC) in online education during COVID-19 pandemic: a comparison of Turkish and Spanish universitie
Akçay Kavakoğlu A.; Güleç Özer D.; Domingo-Callabuig D.; Bilen, Ömer (Emerald Group Holdings Ltd., 2021)Purpose: The paper aims to examine the concept of architectural design communication (ADC) for updating design studio dynamics in architectural education during the Covid-19 pandemic. Within this perspective, the changing ... -
Determinants of pre-radicalization: Religious or Rebel-without-a-cause hypothesis? An empirical test among French adolescents
Roché S.; Bilen, Ömer; Astor S. (IOS Press, 2021)The study of the profiles of young adults involved in attacks and bombings in 2015 and 2016 in France highlighted a violent rejection of Western lifestyle and national identification. The question arises whether conflicting ... -
Oral booster probiotic bifidobacteria in SARS-COV-2 patients
Bozkurt H.S.; Bilen, Ömer (SAGE Publications Inc., 2021)Oral booster-single strain probiotic bifidobacteria could be a potential strategy for SARS-CoV-2. This study aims to evaluate the role of oral probiotic Bifidobacterium on moderate/severe SARS-CoV-2 inpatients. In this ... -
Spatial Distribution Analysis of Syrian Immigrant Population Problem in Fatih - Istanbul
Bilen, Ömer; Gur, Mehmet; Koç, Ersan; KamacI Karahan, Ebru (Konya Technical Univ, Fac Architecture & Design, 2020)Purpose The paper reflects the impacts of the "Arab Spring" that broke out in Tunisia and Syria and led to the loss of more than 300,000 people. A wave of migration began in 2011, especially from Syria to its neighbouring ... -
Strategic analysis of the Turkish over-the-counter drugs and non-pharmaceutical products market [Türkiye tezgah üstü ilaç ve ilaç dışı ürün pazarının stratejik analizi]
Memişoğlu, Merve; Bilen, Ömer (Turkish Pharmacists Association, 2021)Objectives: The over-the-counter (OTC) drug (i.e., non-prescription drugs) market is growing significantly on a global scale. Our study reviews strategies for OTCs, together with other non-pharmaceutical products, such as ...
